Dx Focus: Roche's Cobas TaqMan HIV-1 Test 2.0 | GenomeWeb

Roche this week announced the US availability of the Cobas TaqMan HIV-1 Test v2.0 for use with the High Pure System.

Approved by the US Food and Drug Administration in July, the test is based on the company's proprietary dual-target approach, and enables labs to combine the FDA-approved High Pure process for manual viral nucleic acid preparation with the Cobas TaqMan 48 automated real-time PCR analyzer for amplification and detection.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: Plasmodium knowlesi population structure, 'pre-adaptations' in algal ancestors of land plants, and more.

Replication studies that don't quite reflect the original findings underscore the need to better share data, the Wall Street Journal reports.

About two-thirds of proposals to work with select agents are denied — though most proposals that come in don't meet the definition of a restricted experiment, according to an analysis by the Centers for Disease Control and Prevention.

Researchers examine plant and human DNA found on the Shroud of Turin.